These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32210126)

  • 1. Quality by Design: Development of the Quality Target Product Profile (QTPP) for Semisolid Topical Products.
    Namjoshi S; Dabbaghi M; Roberts MS; Grice JE; Mohammed Y
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality by Design: Concept to Applications.
    Swain S; Parhi R; Jena BR; Babu SM
    Curr Drug Discov Technol; 2019; 16(3):240-250. PubMed ID: 29521238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding pharmaceutical quality by design.
    Yu LX; Amidon G; Khan MA; Hoag SW; Polli J; Raju GK; Woodcock J
    AAPS J; 2014 Jul; 16(4):771-83. PubMed ID: 24854893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Tutorial for Developing a Topical Cream Formulation Based on the Quality by Design Approach.
    Simões A; Veiga F; Vitorino C; Figueiras A
    J Pharm Sci; 2018 Oct; 107(10):2653-2662. PubMed ID: 29935297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluations of Quality by Design (QbD) Elements Impact for Developing Niosomes as a Promising Topical Drug Delivery Platform.
    Shah P; Goodyear B; Haq A; Puri V; Michniak-Kohn B
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32182792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of experiments (DoE) in pharmaceutical development.
    N Politis S; Colombo P; Colombo G; M Rekkas D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):889-901. PubMed ID: 28166428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical framework for implementing Quality by Design to the development of topical drug products: Nanosystem-based dosage forms.
    Simões A; Veiga F; Figueiras A; Vitorino C
    Int J Pharm; 2018 Sep; 548(1):385-399. PubMed ID: 29953928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal Product.
    Pielenhofer J; Meiser SL; Gogoll K; Ciciliani AM; Denny M; Klak M; Lang BM; Staubach P; Grabbe S; Schild H; Radsak MP; Spahn-Langguth H; Langguth P
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From lab to industrial development of lipid nanocarriers using quality by design approach.
    Buya AB; Mahlangu P; Witika BA
    Int J Pharm X; 2024 Dec; 8():100266. PubMed ID: 39050378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical quality by design: product and process development, understanding, and control.
    Yu LX
    Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach.
    Liu H; Rivnay B; Avery K; Myung JH; Kozak D; Landrau N; Nivorozhkin A; Ashraf M; Yoon S
    Int J Pharm; 2020 Jul; 585():119473. PubMed ID: 32473373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QbD Assisted Development of a Compartment and Sequential Drug Delivery System for Periodontotherapy.
    Jain P; Iqbal Z
    Comb Chem High Throughput Screen; 2024 May; ():. PubMed ID: 38752641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation.
    Pallagi E; Ambrus R; Szabó-Révész P; Csóka I
    Int J Pharm; 2015 Aug; 491(1-2):384-92. PubMed ID: 26134895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic development of topical dermatologic products, Part II: quality by design for topical semisolid products.
    Chang RK; Raw A; Lionberger R; Yu L
    AAPS J; 2013 Jul; 15(3):674-83. PubMed ID: 23572241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Silicone-Containing Semisolid in Situ Film-Forming Systems Using QbD Tools.
    Kis N; Kovács A; Budai-Szűcs M; Gácsi A; Csányi E; Csóka I; Berkó S
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31817871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality by Design Applied to Ocular Solid Lipid Nanoparticles Containing a Hydrophilic Peptide Prepared via Hot High Pressure Homogeniser.
    Mercuri AM
    Curr Drug Deliv; 2016; 13(8):1247-1260. PubMed ID: 27012669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing quality by design for biotech products: Are regulators on track?
    Luciani F; Galluzzo S; Gaggioli A; Kruse NA; Venneugues P; Schneider CK; Pini C; Melchiorri D
    MAbs; 2015; 7(3):451-5. PubMed ID: 25853461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems.
    Mohseni-Motlagh SF; Dolatabadi R; Baniassadi M; Baghani M
    Polymers (Basel); 2023 Nov; 15(22):. PubMed ID: 38006131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools.
    Saydam M; Takka S
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1905-1917. PubMed ID: 29969042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.
    Amasya G; Aksu B; Badilli U; Onay-Besikci A; Tarimci N
    Int J Pharm; 2019 May; 563():110-121. PubMed ID: 30935913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.